chunk_id stringlengths 16 20 | chunk stringlengths 1 891 | source_url stringlengths 13 16 | title stringclasses 1
value | chunk_idx int64 0 38 | chunk_start_char int64 0 9.35k | chunk_end_char int64 2 9.84k |
|---|---|---|---|---|---|---|
corpus-test-0#c0 | U.S. SECURITIES AND EXCHANGE COMMISSION
PDF Copy of Submission on SEC EDGAR system
This PDF document is a copy of the following submission on the SEC's EDGAR system:
Submission/Form 10-K
Filed 2025-02-14
Accession number 0000019617-25-000270
Submitted on EDGAR account of JPMORGAN CHASE & CO, CIK 0000019617
This copy wa... | corpus-test-0 | 0 | 0 | 342 | |
corpus-test-0#c1 | -27. | corpus-test-0 | 1 | 342 | 346 | |
corpus-test-0#c2 | The submission itself is available on SEC's public EDGAR database at:
htw.:/wwwwwww....o.ooooo.0oo2/22 000270-index.html.
Additional submission information is available on SEC.gov, including but not limited to whether any additional reportina entities are associated with the submission. | corpus-test-0 | 2 | 347 | 634 | |
corpus-test-1#c0 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
Annual report pursuant to Section 13 or 15 (d)
the Securities Exchange Act of 1934
Commission file
number 1-5805
For the fiscal year ended December 31, 2024
JPMorgan Chase &Co
(Exact name of registrant as specified in its charter)
Delawar... | corpus-test-1 | 0 | 0 | 396 | |
corpus-test-1#c1 | (I.R.S. | corpus-test-1 | 1 | 396 | 403 | |
corpus-test-1#c2 | employer identification no.) | corpus-test-1 | 2 | 404 | 432 | |
corpus-test-1#c3 | 383 Madison Avenue,
New York, New York
10179 (Zip Code)
(Address of principal executive offices)
Registrant's telephone number, including area code: (212) 270-6000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered The New York Sto... | corpus-test-1 | 3 | 433 | 886 | |
corpus-test-1#c4 | D
The New York Stock Exchange
Preferred Stock, Series DD
Depositary Shares, each representing one-four hundredth interest in share of 6.00% Non-Cumulative
JPM PR C
The New York Stock Exchange
Preferred Stock, Series EE
Depositary Shares, each representing one-four hundredth interest in share of 4.75% Non-Cumulative
JP... | corpus-test-1 | 4 | 886 | 1,376 | |
corpus-test-1#c5 |
The New York Stock Exchange
Preferred Stock, Series Ij
Depositary Shares, each representing one-four hundredth interest in share of 4.625% Non-Cumulative
JPM PR
The New York Stock Exchange
Preferred Stock, Series LL
Depositary Shares, each representing one-four hundredth interest in share of 4.20% Non-Cumulative Prefe... | corpus-test-1 | 5 | 1,376 | 1,856 | |
corpus-test-1#c6 | 32
The New York Stock Exchange NYSE Arca, Inc. | corpus-test-1 | 6 | 1,856 | 1,902 | |
corpus-test-1#c7 | Guarantee of Alerian MLP Index ETNs due January 28, 2044 of JPMorgan Chase Financial Company LLC
AMJB
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. [ Yes 8 No
Indicate by check mark... | corpus-test-1 | 7 | 1,903 | 2,325 | |
corpus-test-1#c8 | о Yes 8 No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing... | corpus-test-1 | 8 | 2,326 | 2,681 | |
corpus-test-1#c9 | [ Yes Ne
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (5 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). [... | corpus-test-1 | 9 | 2,682 | 3,190 | |
corpus-test-1#c10 | See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting
Emerging growth company
company
If an emerging growth company, indicate b... | corpus-test-1 | 10 | 3,191 | 3,720 | |
corpus-test-1#c11 | Indicate by check mark whether the registrant has filed report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its a... | corpus-test-1 | 11 | 3,721 | 4,053 | |
corpus-test-1#c12 | ( Yes [ No
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously Issued financial statements..
Indicate by check mark whether any of those error corrections are ... | corpus-test-1 | 12 | 4,054 | 4,571 | |
corpus-test-1#c13 | Indicate by check mark whether the registrant is shell company (as defined in Rule 12b-2 of the Exchange Act). | corpus-test-1 | 13 | 4,572 | 4,682 | |
corpus-test-1#c14 | Yes [ No
The aggregate market value of jPMorgan Chase & Co. common stock held by non-affiliates as of June 30, 2024: $573,,43,601,053
Number of shares of common stock outstanding as of January 31, 2025: 2,796,106,099
Documents Incorporated by reference: Portions of the registrant's Proxy Statement for the annual meeti... | corpus-test-1 | 14 | 4,684 | 5,083 | |
corpus-test-1#c15 | this Form 10-K in response to Items 10, 11, 12, 13 and 14 of Part III. | corpus-test-1 | 15 | 5,083 | 5,154 | |
corpus-test-1#c16 | | New York, New York | | |
| (Address of principal executive offices) | 10179 (Zip Code) | |
| Registrant's telephone number, including | area code: (212) 270-6000 12(b) the of Act: | |
| Securities registered pursuant to Section | | |
| Title of each class Common stock | Trading Symbol(s) JPM | The New York Stoc... | corpus-test-1 | 16 | 5,155 | 5,599 | |
corpus-test-1#c17 | a share of 5.75% Non-Cumulative Preferred Stock, Series DD | JPM PR D | The New York Stock Exchange |
| Depositary Shares, each representing one-four hundredth interest in share of 6.00% Non-Cumulative Preferred Stock, Series EE | JPM PR C | The New York Stock Exchange |
| Depositary Shares, each representing one-four... | corpus-test-1 | 17 | 5,599 | 6,099 | |
corpus-test-1#c18 | th interest in share of 4.55% Non-Cumulative | JPM PR K | The New York Stock Exchange |
| Preferred Stock, Series JJ Depositary Shares, each representing one-four hundredth interest in a share of 4.625% Non-Cumulative Preferred Stock, Series LL | JPM PR | The New York Stock Exchange |
| Depositary Shares, each represen... | corpus-test-1 | 18 | 6,099 | 6,598 | |
corpus-test-1#c19 | due June 10, 2032 of JPMorgan Chase Financial Company LLC | JPM/32 | The New York Stock Exchange |
| Guarantee of Alerian MLP Index ETNs due January 28, 2044 of JPMorgan Chase Financial Company LLC | AMJB | NYSE Arca, Inc. |
| Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if t... | corpus-test-1 | 19 | 6,598 | 7,008 | |
corpus-test-1#c20 | Yes & No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. | corpus-test-1 | 20 | 7,009 | 7,142 | |
corpus-test-1#c21 | Yes 8 No | | |
| Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such | of the Securities filing requirements | Exchange Act of 1934 durin... | corpus-test-1 | 21 | 7,143 | 7,523 | |
corpus-test-2#c0 | Part I
Human capital
|PMorganChase believes that its long-term growth and success depend on its ability to attract, develop and retain talented employees and foster an inclusive work environment. The information provided below relates to JPMorganChase's full-time and part-time employees and does not include the Firm's ... | corpus-test-2 | 0 | 0 | 578 | |
corpus-test-2#c1 | JPMorganChase's employees are located in 66 countries, with 59% of the Firm's employees located in the U.S. | corpus-test-2 | 1 | 579 | 686 | |
corpus-test-2#c2 | The following table presents the distribution of the Firm's global workforce by region and by line of business ("LOB") and Corporate as of December 31, 2024:
| Global workforce increase was primarily attributable to located in 66 countries, with 59% of the As of December 31, 2024, JPMorganChase had 317,233 employees gl... | corpus-test-2 | 2 | 687 | 1,133 | |
corpus-test-2#c3 | JPMorganChase's employees are Firm's employees located in the U.S. The following table presents the distribution of the Firm's global workforce by region and by line of business ("LOB") and Corporate | | As of December 31, 2024, JPMorganChase had 317,233 employees globally, an increase of 7,307 employees from the prio... | corpus-test-2 | 3 | 1,134 | 1,595 | |
corpus-test-2#c4 | following table presents the distribution of the Firm's global workforce by region and by line of business ("LOB") and Corporate as of December 31, 2024: |
| Employee Breakdown by Region | | Employee Breakdown by LOB and Corporate |
| Region Employees | | LOB Employees |
| North America | 187,179 | CCB 144,989 |
| A... | corpus-test-2 | 4 | 1,599 | 1,988 | |
corpus-test-2#c5 | 729 | AWM 29,403 |
| Latin America/Caribbean | 5,384 | Corporate 49,610 |
| Total Firm | 317,233 | Total Firm 317,233 |
Workforce composition
Workforce composition
The following table presents information based on voluntary self-identifications by the Firm's employees, including members of the Firm's Operating Committe... | corpus-test-2 | 5 | 1,988 | 2,414 | |
corpus-test-2#c6 | Information on race/ethnicity of employees is categorized based on Equal Employment Opportunity ("EEO") classifications and is presented for U.S. employees who self-identified, and information on gender is presented for global employees who self-identified. Information on race/ethnicity and gender for members of the Op... | corpus-test-2 | 6 | 2,415 | 3,060 | |
corpus-test-2#c7 | tor for U.S. U.S. employees wnn who forieennteee self-iaentirie,, and and information on gender is andsented presented ror for giobal employees employss who such self-Iaentifiedd intormation Information on on
race/ethnicity and gender for members of the Operating Committee and the Board of Directors reflects all such m... | corpus-test-2 | 7 | 3,061 | 3,534 | |
corpus-test-2#c8 | all
| Information on disability status is based | on all U.S. employees and | members of the | Operating | Committee. | corpus-test-2 | 8 | 3,535 | 3,652 | |
corpus-test-2#c9 | | | |
| December 31, 2024 | Total employees | Senior level employees(e) | | Operating Committee | | Board of Directors | |
| | | | | | | | % |
| White | 43 % | 74 | % | 86 | % | 80 | |
| Hispanic | 21 % | 6 | % | 7 | % | | |
| Asian | 20 % | 14 | % | 7 | % | corpus-test-2 | 9 | 3,654 | 3,927 | |
corpus-test-2#c10 | | | |
| Black | 13 % | 5 | % | | | 20 | |
| Other(b) | 3 % | 1 | % | | | | % |
| | | | | | | | % |
| Men | 51 % | 71 | % | 53 | % | 50 | |
| Women | 49 % | 29 | % | 47 | % | 50 | % |
| | | corpus-test-2 | 10 | 3,927 | 4,131 | |
corpus-test-2#c11 | 4 % | 2 | % | 7 | % | | |
| Military veterans(d) | 3 % | 2 | % | | | 10 | % |
| People with disabilities(d) | 5 % | 3 | % | | | | (9) |
(a) Based on EEO metrics. | corpus-test-2 | 11 | 4,131 | 4,300 | |
corpus-test-2#c12 | Presented as a percentage of the respective populations who self-identified race/ethnicity, which was 97% and 95% of the Firm's total U.S.
(a) Based on EEO metrics. Presented as a percentage of the respective populations who self-identified racejethnicity, which was 97% and 95% of the Firm's total U.S. employees and U.... | corpus-test-2 | 12 | 4,301 | 4,738 | |
corpus-test-2#c13 | Information for the Operating Committee includes one member who is based outside of the U.S.
(b) Other includes American Indian or Alaskan Native, Native Hawaiian or Other Pacific Islander, and two or more races/ethnicities.
(c) Presented as a percentage of the respective populations who self-identified gender, which w... | corpus-test-2 | 13 | 4,739 | 5,209 | |
corpus-test-2#c14 | (d) Presented as a percentage of total U.S.-based employees, total U.S.-based senior level employees, all members of the Operating Committee, and all members of the Board o Directors, respectively.
(e) Senior level employees represents employees with the titles of Managing Director and above.
(f) Excludes Brad D. Smith... | corpus-test-2 | 14 | 5,210 | 5,760 | |
corpus-test-3#c0 | Management's discussion and analysis
Reserve uses results under the severely adverse scenario from its supervisory stress test to determine each firm's Stress Capital Buffer ("SCB") requirement for the coming year.
Regulatory capital
The Federal Reserve establishes capital requirements, including well-capitalized stand... | corpus-test-3 | 0 | 0 | 687 | |
corpus-test-3#c1 | The Firm's current SCB requirement is 3. 3.3% and will remain in effect until September 30, 2025. The Firm's Standardized CET1 capital ratio requirement, including regulatory buffers, was 12.3% as of December 31, 2024.
Refer to Capital actions on page 105 for information on actions taken by the Firm's Board of Director... | corpus-test-3 | 1 | 688 | 1,010 | |
corpus-test-3#c2 | Basel Ill Overview
Internal Capital Adequacy Assessment Process
The capital rules under Basel IlI establish minimum capital ratios and overall capital adequacy standards for large and internationally active U.S. BHCs and banks, including the Firm and JPMorgan Chase Bank, N.A. | corpus-test-3 | 2 | 1,011 | 1,287 | |
corpus-test-3#c3 | The minimum amount of regulatory capital that must be held by BHCs and banks is determined by calculating RWA, which are on-balance sheet assets and off- balance sheet exposures, weighted according to risk, Under the rules currently in effect, two comprehensive approaches are prescribed for calculating RWA: a standardi... | corpus-test-3 | 3 | 1,288 | 1,961 | |
corpus-test-3#c4 | The Firm's ICAAP integrates stress testing protocols with capital planning. The Firm's Audit Committee is responsible for reviewing and approving the capital planning framework.
Stress testing assesses the potential impact of alternative economic and business scenarios on the Firm's earnings and capital. Economic scena... | corpus-test-3 | 4 | 1,962 | 2,629 | |
corpus-test-3#c5 | The scenarios are intended to capture and stress key vulnerabilities and idiosyncratic risks facing the Firm. In addition to CCAR and other periodic stress testing, management also considers tailored stress scenarios and sensitivity analyses, as necessary.
For each of these risk based capital ratios, the capital adequa... | corpus-test-3 | 5 | 2,630 | 3,279 | |
corpus-test-3#c6 | Key differences in the calculation of credit risk RWA between the Standardized and Advanced approaches are that for Basel III Advanced, credit risk RWA is based on risk-sensitive approaches which largely rely on the use of internal credit models and parameters, whereas for Basel III Standardized, credit risk RWA is gen... | corpus-test-3 | 6 | 3,280 | 3,974 | |
corpus-test-3#c7 | Contingency Capital Plan
The Firm's Contingency Capital Plan establishes the capital management framework for the Firm and specifies the principles underlying the Firm's approach towards capital management in normal economic conditions and in stressed environments. The Contingency Capital Plan defines how the Firm cali... | corpus-test-3 | 7 | 3,975 | 4,595 | |
corpus-test-3#c8 | As of December 31, 2024, the Firm's Basel III Standardized ratios risk-based ratios were more binding than the Basel III Advanced risk-based ratios.
Additionally, Basel III requires that Advanced Approaches banking organizations, including the Firm, calculate their SLRs.
Refer to page 104 for additional information on ... | corpus-test-3 | 8 | 4,596 | 4,955 | |
corpus-test-4#c0 | Key Regulatory Developments
Key Regulatory Developments
U.S. Basel IlI Finalization
In July 2023, the Federal Reserve, the OCC and the FDIC released a proposal to amend the risk-based capital framework, entitled "Regulatory capital rule: Amendments applicable to large banking organizations and to banking organizations ... | corpus-test-4 | 0 | 0 | 590 | |
corpus-test-4#c1 | In addition, the stress capital buffer requirement would be applicable to both the expanded risk-based approach and the Standardized approach.
GSIB Surcharge and TLAC and Eligible LTD Requirements In July 2023, the Federal Reserve released a proposal to amend the calculation of the GSIB surcharge. Under the proposal, t... | corpus-test-4 | 1 | 591 | 1,231 | |
corpus-test-4#c2 | The proposed changes would revise risk-based capital requirements for the Firm and other U.S. GSIBs. Refer to Risk- based Capital Regulatory Requirements on page 100 for further information on the GSIB surcharge.
Additionally, in August 2023, the Federal Reserve, the FDIC and the OCC released proposal to expand the eli... | corpus-test-4 | 2 | 1,232 | 1,774 | |
corpus-test-4#c3 | The proposal would also reduce the amount of LTD with remaining maturities of less than two years that count towards a U.S. GSIB's TLAC requirement and expand the existing capital deduction framework for LTD issued by GSIBs to include LTD issued by non-GSIB banks subject to the LTD requirements.
Finalization of the abo... | corpus-test-4 | 3 | 1,775 | 2,267 | |
corpus-test-5#c0 | Under the Federal Reserve's GSIB rule, the Firm is required to assess its GSIB surcharge on an annual basis under two separately prescribed methods based on data for the previous fiscal year-end, and is subject to the higher of the two. "Method 1" reflects the GSIB surcharge as prescribed by the Basel Committee's asses... | corpus-test-5 | 0 | 0 | 467 | |
corpus-test-5#c1 | "Method 2" modifies the Method 1 requirements to include a measure of short-term wholesale funding in place of substitutability, and introduces a GSIB score "multiplication factor".
Management's discussion and analysis
Standardized Advanced Standardized Advanced Standardized Advanced 4Q23 1Q24-3Q24 Certain banking orga... | corpus-test-5 | 1 | 468 | 913 | |
corpus-test-5#c2 | The capital conservation buffer incorporates a GSIB surcharge, a discretionary countercyclical capital buffer and a fixed capital conservation buffer of 2.5% for Advanced regulatory capital requirements, as well as a variable SCB requirement, floored at 2.5%, for Standardized regulatory capital requirements. The U.S. f... | corpus-test-5 | 2 | 914 | 1,476 | |
corpus-test-5#c3 | The buffer can be increased FDIC and the OCC determine that syst above normal and can be calibrated ul RWA subject to a 12-month implement Failure to maintain regulatory capital c risk-based regulatory capital minimum conservation buffer (inclusive of the G countercyclical buffer will result in limi capital that the Fi... | corpus-test-5 | 3 | 1,477 | 2,007 | |
corpus-test-5#c4 | For 2025, the Firm's effective regulatory minimum GSIB surcharge calculated
0% 2% 4% 6% 8% 10% 12% 14% 16%
Capital conservation buffer incl. | corpus-test-5 | 4 | 2,008 | 2,148 | |
corpus-test-5#c5 | IB & SCB Stress capital buffer Fixed capital conservation buffer GSIB surcharge Minimum requirement
12.3% 11.9% 11.5% 11.5% 11.0% 3.3% 2.9% 2.9% 2.5% 2.5% 4.0% 4.0% 4.5% 4.5% 4.5% 4.5% 4.5% 4.5% 4.5% 4.5% 4.5% | corpus-test-5 | 5 | 2,151 | 2,361 | |
corpus-test-5#c6 | 4.5%
Risk-based Capital Regulatory Requirements The following chart presents the Firm's Basel III CET1 capital ratio requirements under the Basel IlI rules curren The Firm's Basel IlI Standardized CET1 capital ratio as of December 31, 2024: 15.7% 11.4% 2.5% 4Q24 Method 1 and Method 2 remains unchi respectively. | corpus-test-5 | 6 | 2,361 | 2,673 | |
corpus-test-5#c7 | All banking institutions are currently required to have a minimum CET1 capital ratio of 4.5% of risk-weighted assets. Method Method 2
Risk-based Capital Regulatory Requirements
The following chart presents the Firm's Basel III CET1 capital ratio requirements under the Basel IlI rules currently in effect.
| Advanced | ... | corpus-test-5 | 7 | 2,674 | 3,076 | |
corpus-test-5#c8 | | |
| 2024 | 2023 |
| Method 1 2.5 % Method 2 4.5 % | 2.5 % 4.0 % |
| The U.S. federal regulatory capital standards include a | framework |
| for setting a discretionary countercyclical capital buffer taking | |
| into account the macro financial environment in which large, | |
| internationally active banks functio... | corpus-test-5 | 8 | 3,077 | 3,399 | |
corpus-test-5#c9 | As of December 31, 2024, | |
The U.S. federal regulatory capital standards include a framework for setting discretionary countercyclical capital buffer taking into account the macro financial environment in which large, internationally active banks function. As of December 31, 2024, the U.S. countercyclical capital bu... | corpus-test-5 | 9 | 3,400 | 3,814 | |
corpus-test-5#c10 | The buffer can be increased if the Federal Reserve, the FDIC and the OCC determine that systemic risks are meaningfully above normal and can be calibrated up to an additional 2.5% of RWA subject to a 12-month implementation period.
Failure to maintain regulatory capital equal to or in excess of the risk-based regulator... | corpus-test-5 | 10 | 3,815 | 4,467 | |
corpus-test-5#c11 | JPMorgan Chase &Co./2024 Form 10-K | corpus-test-5 | 11 | 4,468 | 4,502 | |
corpus-test-6#c0 | Other regulatory capital
Total Loss-Absorbing Capacity
capacity The Federal Reserve's TLAC rule requires the U.S. GSIB top-tier holding companies, including the Firm, to maintain minimum levels of external TLAC and eligible LTD. Refer to TLAC on page 106 for additional information.
Leverage-based Capital Regulatory Req... | corpus-test-6 | 0 | 0 | 590 | |
corpus-test-6#c1 | The SLR is defined as Tier 1 capital under Basel IlI divided by the Firm's total leverage exposure. Total leverage exposure is calculated by taking the Firm's total average on-balance sheet assets, less amounts permitted to be deducted for Tier 1 capital, and adding certain off-balance sheet exposures, as defined in re... | corpus-test-6 | 1 | 591 | 987 | |
corpus-test-6#c2 | Failure to maintain an SLR equal to or greater than the regulatory requirement will result in limitations on the amount of capital that the Firm may distribute such as through dividends and common share repurchases, as well as on discretionary bonus payments for certain evecutive officers
In addition to meeting the cap... | corpus-test-6 | 2 | 988 | 1,645 | |
corpus-test-6#c3 | Refer to Note 27 for additional information.
Additional information regarding the Firm's capital ratios, as well as the U.S. federal regulatory capital standards to which the Firm is subject, is presented in Note 27. Refer to the Firm's Pillar 3 Regulatory Capital Disclosures reports, which are available on the Firm's ... | corpus-test-6 | 3 | 1,646 | 2,073 | |
corpus-test-7#c0 | Management's discussion and analysis
III Standardized risk-based and As a result, for is calculated under additional information
data Firm's risk-based Refer to Note 27 to Advanced approach Advanced RWA and provisions in the U.S.
| Selected capital and RWA | | | | | | |
| The following tables present the | | cap... | corpus-test-7 | 0 | 0 | 503 | |
corpus-test-7#c1 | First |
| Republic Bank was not subject | | regulatory | capital requirements. | | certain exposures | associated with the |
| First Republic acquisition, | | any impact on Advanced | Total capital | | the Standardized | approach as |
| permitted by the transition | | capital rules. | Refer to Note 34 for | | on ... | corpus-test-7 | 1 | 504 | 857 | |
corpus-test-7#c2 |
| | | Standardized | | | Advanced | |
| (in millions, except ratios) | December 31, 2024 | December 31, 2023 | Capital ratio requirements | December 31, 2024 | December 31, 2023 | Capital ratio requirements"" |
| Risk-based capital metrics: | | | | | | |
| CET1 capital | 275,513 | 250,585 | | 2 | corpus-test-7 | 2 | 859 | 1,167 | |
corpus-test-7#c3 | 75,513 | $ 250,585 | |
| Tier capital | 294,881 | 277,306 | | 294,881 | 277,306 | |
| Total capital | 325,589 | 308,497 | | 311,898 | 295,417 | |
| Risk-weighted assets | 1,757,460 | | corpus-test-7 | 3 | 1,167 | 1,355 | |
corpus-test-7#c4 | 1,671,995 | | 1,740,429 | 1,669,156 10 | |
| CET1 capital ratio | 15.7 % | 15.0 % | 12.3 % | 15.8 % | 15.0 % | 11.5 % |
| Tier capital ratio | 16.8 | 16.6 | 13.8 | 16.9 | 16.6 | 13. | corpus-test-7 | 4 | 1,355 | 1,538 | |
corpus-test-7#c5 | 0 |
| Total capital ratio | 18.5 | 18.5 | 15.8 | 17.9 | 17.7 | 15.0 |
(a) The capital metrics reflect the CECL capital transition provisions. | corpus-test-7 | 5 | 1,538 | 1,679 | |
corpus-test-7#c6 | of December 31, 2024, CET1 capital reflected the remainings720 million CECL benefit and were fully
311,
| Risk-weighted assets | 1,757,460 | 1,671,995 | | | 1,740,429 | 1,669,156 | (6) | |
| CET1 capital ratio | 15.7 % | 15.0 % | 12.3 % | | 15 | corpus-test-7 | 6 | 1,682 | 1,930 | |
corpus-test-7#c7 | .8 % | 15.0 % | | 11.5 % |
| Tier 1 capital ratio | 16.8 | 16.6 | 13.8 | | 16.9 | 16.6 | | 13.0 |
| Total capital ratio | 18.5 | 18.5 | 15.8 | | 17.9 | 17.7 | | 15.0 |
| (a) The capital metrics reflect the CECL capital transition | corpus-test-7 | 7 | 1,930 | 2,164 | |
corpus-test-7#c8 | | | provisions. | corpus-test-7 | 8 | 2,164 | 2,181 | |
corpus-test-7#c9 | As of December 31, | 2024, CET1 capital | | reflected the remaining$ 720 | million CECL benefit additional information. | | and were fully |
| phased in as of January 1, 2025; as of December 31, 2023, CET1 | | capital reflected | $1.4 billion benefit. Refer to | billion benefit. | corpus-test-7 | 9 | 2,182 | 2,464 | |
corpus-test-7#c10 | Refer to | to Note 27 for | | | |
| (b) Represents minimum requirements and regulatory buffers | | applicable to the Firm for | the period ended | period ended | December 31, 2024. | corpus-test-7 | 10 | 2,465 | 2,649 | |
corpus-test-7#c11 | For the | period ended | | December 31, 2023, the |
| Basel III Standardized CET1, Tier 1, and Total capital ratio requirements | | applicable | to the Firm were 11.4%, | | 12.9%, and 14.9%, | respectively; the | | Basel III Advanced CET1, Tier |
| 1, and Total capital ratio requirements applicable to the Firm | |... | corpus-test-7 | 11 | 2,650 | 3,032 | |
corpus-test-7#c12 | | | additional | information. | |
| (c) Includes the impacts of certain assets associated | with First | Republic to which the | Standardized approach has | approach has | Refer to Note 27 for been applied as permitted | by the | | transition provisions in the U.S. |
| capital rules. | corpus-test-7 | 12 | 3,033 | 3,320 | |
corpus-test-7#c13 | | | | | | | | |
| Three months ended (In millions, ratios) except | | | December 31, 2024 | | December 31, 2023 | | | Capital ratio requirements |
| Leverage-based capital metrics:(a) | | | | | | | | |
| Adjusted average assets(b) | | | | 4,070,499 | $ 3,831,20 | corpus-test-7 | 13 | 3,322 | 3,608 | |
corpus-test-7#c14 | 0 | | | |
| Tier 1 leverage ratio | | | | 7.2 % | 7.2 % | | | 4.0 % |
| Total leverage exposure | | | | 4,837,568 $ | | 4,540,465 | | |
| SLR | | | | 6.1 % | | 6.1 % | | 5.0 % |
| (a) The capital metrics reflect the | corpus-test-7 | 14 | 3,608 | 3,842 | |
corpus-test-7#c15 | CECL capital transition | provisions. | corpus-test-7 | 15 | 3,842 | 3,880 | |
corpus-test-7#c16 | | Refer to Note 27 | | | | | | |
| (b) Adjusted average assets, for purposes of calculating the leverage | | ratios, includes | | | | | that are | subject to deduction |
| from Tier capital, predominantly | goodwill, inclusive of estimated | equity method | | | | | | |
| (c) Represents minimum requirem... | corpus-test-7 | 16 | 3,881 | 4,287 | |
corpus-test-7#c17 | quarterly average assets adjusted goodwill, and other intangible additional Refer to Note 27 for | | for on-balance sheet assets assets. information. | | | |
102 JPMorgan Chase & Co./2024 Form 10-K | corpus-test-7 | 17 | 4,288 | 4,489 | |
corpus-test-8#c0 | equity
| | | stockholders' capital as |
| Capital components | | |
| of December 31, 2024 and 2023. | corpus-test-8 | 0 | 0 | 103 | |
corpus-test-8#c1 | following table presents reconciliations of total to Basel IlI CET1 capital, Tier 1 capital and Total | | |
| (in millions) | December 31, 2024 | December 31, 2023 |
| Total stockholders' equity | $ 344,758 | $ 327,878 |
| Less: Preferred stock | 20,050 | 27,404 |
| Common stockholders' equity | 324,708 | 300 | corpus-test-8 | 1 | 107 | 420 | |
corpus-test-8#c2 | ,474 |
| Certain deferred tax liabilities(a) Add: | 2,943 | 2,996 |
| Other CET1 capital adjustments | 4,499 | 4,717 |
| Less: | | |
| Goodwill(c) | 53,763 | 54,377 |
| Other intangible assets | 2,874 | 3,225 |
| Standardizee/Advvaneed CET1 capital | 275,513 | | corpus-test-8 | 2 | 420 | 682 | |
corpus-test-8#c3 | 250,585 |
| Add: Preferred stock | 20,050 | 27,404 |
| Less: Other Tier 1 adjustments | 682 | 683 |
| Standardizee/Advvaned Tier 1 capital | $ 294,881 | $ 277,306 |
| Long-term debt and other instruments | 10,312 | $ 11,779 |
| qualifying as Tier 2 capital | 10,312 | corpus-test-8 | 3 | 682 | 948 | |
corpus-test-8#c4 | | |
| Qualifying allowance for credit losses(d) | 20,992 | 20,102 |
| Other | (596) | (690) |
| Standardized Tier 2 capital | 30,708 | $ 31,191 |
| Standardized Total capital | $ 325,589 | $ 308,497 |
| Adjustment in qualifying allowance for credit losses for Advanced Tier 2 capital(e)() | (13,691) | ( | corpus-test-8 | 4 | 948 | 1,253 | |
corpus-test-8#c5 | 13,080) |
| Advanced Tier 2 capital | $ 17,017 | 18,111 |
| Advanced Total capital | 311,898 | $ 295,417 |
(a) Represents deferred tax liabilities related to tax-deductible goodwill and to
CET1
$
| Capital rollforward | |
| The following table presents the changes in Basel IlI | capital, |
| Tier 1 capital and Tier 2 ... | corpus-test-8 | 5 | 1,253 | 1,618 | |
corpus-test-8#c6 | 2024. | corpus-test-8 | 6 | 1,618 | 1,624 | |
corpus-test-8#c7 | |
| Year ended December 31, (in millions) | 2024 |
| Standardizeed/Advanced CET1 capital at December 31, 2023 | $ 250,585 |
| Net income applicable to common equity | 57,212 |
| Dividends declared on common stock | (13,786) |
| Net purchase of treasury stock | (17,801) |
| Changes in additional paid-in capital | 783 ... | corpus-test-8 | 7 | 1,626 | 1,973 | |
corpus-test-8#c8 | applicable to capital: | |
| Unrealized gains/(losses) on investment securities | (87) |
| Translation adjustments, net of hedgesta) | (858) |
| Fair value hedges | (87) |
| Defined benefit pension and other postretirement employee benefit ("OPEB") plans | (63) |
| Changes related to other CET1 capital adjustmentsbb)... | corpus-test-8 | 8 | 1,973 | 2,389 | |
corpus-test-8#c9 | 1 capital at December 31, 2024 | 275,513 |
| Standarddzed/Advaaned Tier 1 capital at December 31, 2023 | 277,306 |
| Change in CET1 capital(b) | 24,928 |
| Net redemptions of noncumulative perpetual preferred stock Other | (7,354) 1 |
| Change in Standardizzel/Advancee Tier 1 capital | 17,575 |
| Standardizze | corpus-test-8 | 9 | 2,389 | 2,699 | |
corpus-test-8#c10 | /Addvanced Tier 1 capital at December 31, 2024 | $ 294,881 |
| Standardized Tier 2 capital at December 31, 2023 | $ 31,191 |
| Change in long-term debt and other instruments qualifying as Tier 2 | (1,467) |
| | 890 |
| Change in qualifying allowance for credit lossesbb) Other | 94 |
| Change in Standardized Tier 2 cap... | corpus-test-8 | 10 | 2,699 | 3,048 | |
corpus-test-8#c11 | Tier 2 capital at December 31, 2024 | $ 30,708 |
| Standardized Total capital at December 31, 2024 | $ 325,589 |
| Advanced Tier 2 capital at December 31, 2023 | $ 18,111 |
| Change in long-term debt and other instruments qualifying as Tier 2 | (1,467) |
| | 279 |
| Change in qualifying allowance for credit losseg(bl... | corpus-test-8 | 11 | 3,048 | 3,376 | |
corpus-test-8#c12 | | 94 |
| Change in Advanced Tier 2 capital | (1,094) |
| Advanced Tier 2 capital at December 31, 2024 | $ 17,017 |
| Advanced Total capital at December 31, 2024 | 311,898 |
| (a) Includes foreign currency translation adjustments and the impact of related derivatives. | corpus-test-8 | 12 | 3,376 | 3,644 |
End of preview. Expand in Data Studio
README.md exists but content is empty.
- Downloads last month
- 14